Inflammatory Mediator Profiles in the Unchallenged Sinonasal Mucus of Allergic Rhinitis Patients Set to Begin Allergen Immunotherapy
Int Forum Allergy Rhinol
.
2025 Jul;15(7):751-754.
doi: 10.1002/alr.23583.
Epub 2025 Apr 4.
Authors
Cameron P Worden
1
,
Adam M Speen
2
3
,
Meghan E Rebuli
2
3
4
,
Ilona Jaspers
2
3
4
,
Brian D Thorp
1
,
Cristine N Klatt-Cromwell
1
,
Brent A Senior
1
,
Adam J Kimple
1
3
,
Charles S Ebert Jr
1
Affiliations
1
Department of Otolaryngology-Head & Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, USA.
2
Curriculum in Toxicology and Environmental Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
3
Center for Environmental Medicine, Asthma, and Lung Biology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
4
Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
PMID:
40183757
DOI:
10.1002/alr.23583
No abstract available
Keywords:
Allergen Immunotherapy; Allergic Rhinitis; Chemokines; Cytokines; RMS; RQLQ; Sinonasal.
Grants and funding
5T32DC005360/DC/NIDCD NIH HHS/United States
5T32DC005360/DC/NIDCD NIH HHS/United States